NEW YORK (Reuters Health) – Patients with hypercholesterolemia who do not reach target lipid levels with rosuvastatin have a better change of reaching their goals by adding ezetimibe…
NEW YORK (Reuters Health) – For patients with acute MI given early unfractionated heparin, a switch to bivalirudin before undergoing primary percutaneous coronary intervention results in improved cardiac…
NEW YORK (Reuters Health) – After catheter ablation, patients with obstructive sleep apnea (OSA) are more likely to experience recurrence of atrial fibrillation (AF) than are their OSA-free…
Teresa L. Knight, MD, FACOG, Chief Medical Officer of the Women’s Health Specialists of Saint Louis, discusses the risk of cardiovascular disease among women and how to prevent…
NEW YORK (Reuters Health) – The estimated 10-year risk for coronary heart disease (CHD) among adults with diabetes has declined significantly in the past decade, according to a…
NEW YORK (Reuters Health) – The combination of niacin and fenofibrate, along with diet and exercise, markedly improves the lipid profile of HIV patients on antiretroviral therapy (ART),…
NEW YORK (Reuters Health) – In patients with both carotid and coronary stenosis, a percutaneous approach to treating both sites — simultaneously or within a close period —…
NEW YORK (Reuters Health) – Pooled data from four TAXUS trials show that at 5 years, target lesion revascularization rates are consistently lower when the paclitaxel-eluting stent (PES)…
NEW YORK (Reuters Health) – In patients with impaired renal function, the type of nonionic contrast agent used for coronary angiography seems to make little difference to the…
NEW YORK (Reuters Health) – Cotreatment with an angiotensin-converting enzyme (ACE) inhibitor reduces the risk of diabetes associated with beta blocker treatment, according to a report in the…